Cargando…

Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma

BACKGROUND: Postoperative interferon-α(IFN-α) treatment delays hepatocellular carcinoma(HCC) recurrence and prolongs patient survival, and may thus be an effective form of adjuvant therapy. However, clinical observations found that HCC recurs in some patients within 8 months of IFN-α treatment being...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ju-Bo, Sun, Hui-Chuan, Jia, Wei-Dong, Zhuang, Peng-Yuan, Qian, Yong-Bing, Zhu, Xiao-Dong, Kong, Ling-Qun, Wang, Lu, Wu, Wei-Zhong, Tang, Zhao-You
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517454/ https://www.ncbi.nlm.nih.gov/pubmed/23025904 http://dx.doi.org/10.1186/1471-2407-12-439

Ejemplares similares

Direct Transformation of Lung Microenvironment by Interferon-α Treatment Counteracts Growth of Lung Metastasis of Hepatocellular Carcinoma
por: Zhuang, Peng-Yuan, et al.
Publicado: (2013)

Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma
por: Ji, Junfang, et al.
Publicado: (2013)

Acute and Sub-chronic Toxicity Study of Recombinant Bovine Interferon Alpha in Rodents
por: Yu, Hai-Yang, et al.
Publicado: (2021)

Combined Cis-platinum and Alpha Interferon Therapy of Advanced Hepatocellular Carcinoma
por: Ji, Sang Keun, et al.
Publicado: (1996)

Interferon-alpha-2b induces autophagy in hepatocellular carcinoma cells through Beclin1 pathway
por: Zhao, Jun, et al.
Publicado: (2014)

Cloning, expression and antiviral activity of mink alpha-interferons
por: Zhang, Hai-ling, et al.
Publicado: (2015)

Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma
por: Song, Wei, et al.
Publicado: (2016)

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography
por: Zhu, Xiao-Dong, et al.
Publicado: (2011)

Propionibacterium acnes-associated Sarcoidosis Possibly Initially Triggered by Interferon-alpha Therapy
por: Sawahata, Michiru, et al.
Publicado: (2020)

Interferon-alpha therapy for refractory kaposiform hemangioendothelioma: a single-center experience
por: Wu, Hai Wei, et al.
Publicado: (2016)

Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma
por: Lu, Lu, et al.
Publicado: (2013)

Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998)

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial
por: Li, Chuan, et al.
Publicado: (2021)

Antrodia cinnamomea Suppress Dengue Virus Infection through Enhancing the Secretion of Interferon-Alpha
por: Chen, Yi-Ju, et al.
Publicado: (2022)

Inflammatory signaling compromises cell responses to interferon alpha
por: HuangFu, Wei-Chun, et al.
Publicado: (2011)

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study
por: Lin, Chih Ying, et al.
Publicado: (2020)

Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma
por: Wei, Tao, et al.
Publicado: (2014)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
por: Sun, Hui-Chuan, et al.
Publicado: (2021)

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.
por: Lai, C. L., et al.
Publicado: (1989)

Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010)

Interferon Alpha Association with Neuromyelitis Optica
por: Asgari, Nasrin, et al.
Publicado: (2013)

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma
por: Kong, Ling-Qun, et al.
Publicado: (2013)

Nomogram Based on Platelet–Albumin–Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients
por: Yang, Chengkai, et al.
Publicado: (2023)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
por: Wittling, Megen C., et al.
Publicado: (2021)

Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma
por: Mai, Rong-Yun, et al.
Publicado: (2019)

Interferon: A Sharp Sword to Overcome HCV or HBV-Related Liver Diseases?
por: Jia, Wei-Dong, et al.
Publicado: (2010)

Failure of high doses of alpha interferon to affect the growth of human carcinoma, melanoma, and myeloid leukaemia xenografts.
por: Clutterbuck, R. D., et al.
Publicado: (1983)

Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection
por: Fan, He Bin, et al.
Publicado: (2012)

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005)

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels
por: Hsu, Po‐Yao, et al.
Publicado: (2021)

Deciphering the molecular basis of arsenic/interferon-alpha induced eradication of leukemia initiating cells in adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2015)

Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin
por: Mathew, Abraham, et al.
Publicado: (2006)

Interferon-γ release assays for tuberculous meningitis diagnosis: a meta-analysis
por: Lan, You, et al.
Publicado: (2020)

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation
por: He, Jia-Jia, et al.
Publicado: (2021)

Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta
Publicado: (1988)

Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhuang, Liping, et al.
Publicado: (2013)

Acute Q Fever Presenting with Multi-Organ Failure: Re-Evaluation of the Initial Diagnosis
por: Villalba, Noel Lorenzo, et al.
Publicado: (2016)

Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea
por: Kim, Jie-Hyun, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_3d8ace0mu7bmmv0gvqm4sj4ib6